iBio, Inc.
USD1.73
-0.01 (-0.29%)
CEO
Martin Brenner
IPO Date
2008-08-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.73
Prev. Close
$1.73
Day Low
$1.71
Day High
$1.75
52W Low
$0.56
52W High
$3.82
Market Cap
$0.03B
Volume
0.14M
| -0.3 |
| 30 Jun 2023 | FY | 0.0% | 0.0% | -422.7% | -157.8% | 1.11 | 1.22 | -0.1 |
| 30 Jun 2022 | FY | -101.2% | -2674.7% | -79.4% | -50.7% | 0.41 | 1.48 | -0.0 |
| 30 Jun 2021 | FY | 38.3% | -978.8% | -21.4% | -15.8% | 0.30 | 15.74 | -12.7 |
| 30 Jun 2020 | FY | 57.1% | -1003.6% | -29.0% | -17.5% | 0.58 | 11.79 | -8.5 |
| 30 Jun 2019 | FY | 100.0% | -871.8% | -714.3% | -57.5% | 10.10 | 1.39 | -0.8 |
| 30 Jun 2018 | FY | 100.0% | -3627.3% | -99.6% | -37.4% | 1.55 | 8.00 | -0.6 |
| 30 Jun 2017 | FY | 100.0% | -3688.3% | -163.0% | -40.4% | 2.83 | 4.26 | -2.4 |
| 30 Jun 2016 | FY | 100.0% | -1030.0% | -98.3% | -18.9% | 2.56 | 10.43 | -6.0 |
| -5.3 |
| 30 Sept 2025 | Q1 | -189.0% | -5720.0% | -10.2% | -8.9% | 0.06 | 8.39 | -1.9 |
| 30 Jun 2025 | Q4 | 100.0% | -2581.5% | -34.7% | -22.3% | 0.24 | 1.59 | -0.6 |
| 31 Mar 2025 | Q3 | 0.0% | 0.0% | -42.7% | -25.4% | 0.33 | 1.12 | -2.0 |
| 31 Dec 2024 | Q2 | 100.0% | -2182.0% | -31.4% | -20.1% | 0.29 | 1.76 | -1.3 |
| 30 Sept 2024 | Q1 | 0.0% | 0.0% | -22.5% | -16.3% | 0.24 | 3.37 | -1.2 |
| 30 Jun 2024 | Q4 | -60.6% | -4444.6% | -36.5% | -27.1% | 0.21 | 4.08 | -0.6 |
| 31 Mar 2024 | Q3 | 0.0% | 0.0% | -12.8% | -6.3% | 0.70 | 1.69 | -1.0 |
| 31 Dec 2023 | Q2 | 0.0% | 0.0% | -89.3% | -24.1% | 1.88 | 0.91 | -0.1 |